Home › Endometrial Cancer › Ohio › Dayton

Endometrial Cancer clinical trials in Dayton, OH

7 studies for Endometrial Cancer are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecruitingPhase 2

Miami Valley Hospital, Dayton
Premier Blood and Cancer Center, Dayton
Miami Valley Hospital North, Dayton
and 5 more

All ages · All sexes · Updated Oct 2, 2026 · NCT05564377

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

RecruitingPhase 2

Miami Valley Hospital South, Centerville · 9 mi away

Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05112601

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

RecruitingPhase 3

Kettering Health Main Campus-Kettering Health Cancer Center ( Site 5001), Kettering · 5 mi away
Miami Valley Hospital South ( Site 6014), Centerville · 9 mi away

Ages 18 and older · Women · Updated Sep 17, 2026 · NCT06952504